{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T23:02:40Z","timestamp":1778799760359,"version":"3.51.4"},"reference-count":109,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T00:00:00Z","timestamp":1696464000000},"content-version":"vor","delay-in-days":96,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005674","name":"Cystinosis Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005674","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004095","name":"Kyowa Hakko Kirin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010795","name":"Chugai Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023772","name":"National Center of Competence in Research Spin Qubit in Silicon","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023772","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000191","name":"Kidney Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seminarsinnephrology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.semnephrol.2023.151437","type":"journal-article","created":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T07:05:02Z","timestamp":1699945502000},"page":"151437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Tubular Diseases and Stones Seen From Pediatric and Adult Nephrology Perspectives"],"prefix":"10.1016","volume":"43","author":[{"given":"Johannes","family":"M\u00fcnch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul R.","family":"Goodyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten A.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.semnephrol.2023.151437_bib0001","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJMoa1806891","article-title":"Diagnostic utility of exome sequencing for kidney disease","volume":"380","author":"Groopman","year":"2019","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151437_bib0002","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1681\/ASN.2022060725","article-title":"Genomic disorders in CKD across the lifespan","volume":"34","author":"Verbitsky","year":"2023","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151437_bib0003","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1038\/ki.1996.254","article-title":"The aquaporin family of water channels in kidney: an update on physiology and pathophysiology of aquaporin-2","volume":"49","author":"Nielsen","year":"1996","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151437_bib0004","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1172\/JCI118834","article-title":"Expression of the Na-K-2Cl cotransporter by macula densa and thick ascending limb cells of rat and rabbit nephron","volume":"98","author":"Oberm\u00fcller","year":"1996","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.semnephrol.2023.151437_bib0005","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nrneph.2015.89","article-title":"Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus","volume":"11","author":"Bockenhauer","year":"2015","journal-title":"Nat Rev Nephrol"},{"issue":"12","key":"10.1016\/j.semnephrol.2023.151437_bib0006","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1007\/s00467-012-2118-8","article-title":"Congenital nephrogenic diabetes insipidus: the current state of affairs","volume":"27","author":"Wesche","year":"2012","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151437_bib0007","doi-asserted-by":"crossref","first-page":"186","DOI":"10.7326\/0003-4819-144-3-200602070-00007","article-title":"Nephrogenic diabetes insipidus","volume":"144","author":"Sands","year":"2006","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.semnephrol.2023.151437_bib0008","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1172\/JCI8688","article-title":"Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants","volume":"105","author":"Morello","year":"2000","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151437_bib0009","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1172\/JCI2605","article-title":"An aquaporin-2 water channel mutant which causes autosomal dominant nephrogenic diabetes insipidus is retained in the Golgi complex","volume":"102","author":"Mulders","year":"1998","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.semnephrol.2023.151437_bib0010","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/hmg\/11.7.779","article-title":"Heteroligomerization of an aquaporin-2 mutant with wild-type aquaporin-2 and their misrouting to late endosomes\/lysosomes explains dominant nephrogenic diabetes insipidus","volume":"11","author":"Marr","year":"2002","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151437_bib0011","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1086\/323643","article-title":"Three families with autosomal dominant nephrogenic diabetes insipidus caused by aquaporin-2 mutations in the C-terminus","volume":"69","author":"Kuwahara","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151437_bib0012","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1083\/jcb.200309017","article-title":"Reversed polarized delivery of an aquaporin-2 mutant causes dominant nephrogenic diabetes insipidus","volume":"163","author":"Kamsteeg","year":"2003","journal-title":"J Cell Biol"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151437_bib0013","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1592\/phco.29.5.613","article-title":"Nephrogenic diabetes insipidus induced by two amphotericin B liposomal formulations","volume":"29","author":"Metzger","year":"2009","journal-title":"Pharmacotherapy"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151437_bib0014","doi-asserted-by":"crossref","first-page":"458","DOI":"10.2169\/internalmedicine.44.458","article-title":"Amphotericin B-induced nephrogenic diabetes insipidus in a case of cryptococcemia","volume":"44","author":"Fujita","year":"2005","journal-title":"Intern Med"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151437_bib0015","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0272-6386(96)90369-8","article-title":"Nephrogenic diabetes insipidus and renal tubular acidosis secondary to foscarnet therapy","volume":"27","author":"Navarro","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2023.151437_bib0016","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3389\/fonc.2020.00779","article-title":"Electrolyte disorders induced by antineoplastic drugs","volume":"10","author":"Verzicco","year":"2020","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151437_bib0017","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0959-8049(94)00418-5","article-title":"Nephrogenic diabetes insipidus following high dose epirubicin chemotherapy for metastatic soft tissue sarcoma","volume":"31A","author":"Vasey","year":"1995","journal-title":"Eur J Cancer"},{"issue":"suppl 16","key":"10.1016\/j.semnephrol.2023.151437_bib0018","first-page":"S43","article-title":"Lithium-induced nephrogenic diabetes insipidus: new clinical and experimental findings","volume":"23","author":"Trepiccione","year":"2010","journal-title":"J Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151437_bib0019","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/0891988712436690","article-title":"The effects of lithium on renal function in older adults\u2013a systematic review","volume":"25","author":"Rej","year":"2012","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151437_bib0020","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1681\/ASN.V103666","article-title":"Lithium intoxication","volume":"10","author":"Timmer","year":"1999","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151437_bib0021","doi-asserted-by":"crossref","first-page":"C952","DOI":"10.1152\/ajpcell.00266.2003","article-title":"Changes in cellular composition of kidney collecting duct cells in rats with lithium-induced NDI","volume":"286","author":"Christensen","year":"2004","journal-title":"Am J Physiol Cell Physiol"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151437_bib0022","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.2215\/CJN.01640408","article-title":"Lithium-induced nephrogenic diabetes insipidus: renal effects of amiloride","volume":"3","author":"Bedford","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2023.151437_bib0023","unstructured":"Knoers N, Lemmink H. Hereditary Nephrogenic Diabetes Insipidus. 2000 [Updated 2020 Feb 27]. In: Adam MP, Feldman J, Mirzaa GM, et al., editors. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2023. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1177\/"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151437_bib0024","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/ckj\/sfy027","article-title":"Long-term outcome in inherited nephrogenic diabetes insipidus","volume":"12","author":"Sharma","year":"2019","journal-title":"Clin Kidney J"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151437_bib0025","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/ki.2009.91","article-title":"Amiloride blocks lithium entry through the sodium channel thereby attenuating the resultant nephrogenic diabetes insipidus","volume":"76","author":"Kortenoeven","year":"2009","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151437_bib0026","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/0002-9343(78)90794-5","article-title":"Evidence for a prostaglandin-independent defect in chloride reabsorption in the loop of Henle as a proximal cause of Bartter's syndrome","volume":"65","author":"Gill","year":"1978","journal-title":"Am J Med"},{"issue":"8","key":"10.1016\/j.semnephrol.2023.151437_bib0027","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00424-022-02725-4","article-title":"The importance of kidney calcium handling in the homeostasis of extracellular fluid calcium","volume":"474","author":"Prot-Bertoye","year":"2022","journal-title":"Pflugers Arch"},{"issue":"8","key":"10.1016\/j.semnephrol.2023.151437_bib0028","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1681\/ASN.2005101071","article-title":"Late-onset manifestation of antenatal Bartter syndrome as a result of residual function of the mutated renal Na+-K+-2Cl- co-transporter","volume":"17","author":"Pressler","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.semnephrol.2023.151437_bib0029","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1681\/ASN.2016101057","article-title":"Clinical and genetic spectrum of Bartter syndrome type 3","volume":"28","author":"Seys","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151437_bib0030","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0002-9343(01)01086-5","article-title":"Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies","volume":"112","author":"Peters","year":"2002","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151437_bib0031","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ng752","article-title":"Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure","volume":"29","author":"Birkenh\u00e4ger","year":"2001","journal-title":"Nat Genet"},{"issue":"13","key":"10.1016\/j.semnephrol.2023.151437_bib0032","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1056\/NEJMoa032843","article-title":"Salt wasting and deafness resulting from mutations in two chloride channels","volume":"350","author":"Schlingmann","year":"2004","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.semnephrol.2023.151437_bib0033","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1056\/NEJMoa1507629","article-title":"Polyhydramnios, transient antenatal Bartter's syndrome, and MAGED2 mutations","volume":"374","author":"Laghmani","year":"2016","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151437_bib0034","doi-asserted-by":"crossref","first-page":"242","DOI":"10.2215\/CJN.05670517","article-title":"Prevalence of novel MAGED2 mutations in antenatal Bartter syndrome","volume":"13","author":"Legrand","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.semnephrol.2023.151437_bib0035","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1007\/s00467-011-1871-4","article-title":"Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects","volume":"26","author":"Seyberth","year":"2011","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151437_bib0036","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/01.PCC.0000059422.26706.64","article-title":"Successful management of an extreme example of neonatal hyperprostaglandin-E syndrome (Bartter's syndrome) with the new cyclooxygenase-2 inhibitor rofecoxib","volume":"4","author":"Haas","year":"2003","journal-title":"Pediatr Crit Care Med"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151437_bib0037","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.kint.2020.10.035","article-title":"Diagnosis and management of Bartter syndrome: executive summary of the consensus and recommendations from the European Rare Kidney Disease Reference Network Working Group for Tubular Disorders","volume":"99","author":"Konrad","year":"2021","journal-title":"Kidney Int"},{"issue":"10","key":"10.1016\/j.semnephrol.2023.151437_bib0038","doi-asserted-by":"crossref","first-page":"5641","DOI":"10.3390\/ijms23105641","article-title":"Clinical and genetic characterization of patients with Bartter and Gitelman syndrome","volume":"23","author":"Palazzo","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151437_bib0039","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00467-018-4135-8","article-title":"Effect of nonsteroidal anti-inflammatory drugs in children with Bartter syndrome","volume":"34","author":"Gasongo","year":"2019","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151437_bib0040","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/MAJ.0b013e31819f1ed8","article-title":"Bartter's syndrome in pregnancy: review of potassium homeostasis in gestation","volume":"338","author":"Luqman","year":"2009","journal-title":"Am J Med Sci"},{"issue":"9","key":"10.1016\/j.semnephrol.2023.151437_bib0041","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1056\/NEJM200008313430915","article-title":"New treatment options for Bartter's syndrome","volume":"343","author":"Kleta","year":"2000","journal-title":"N Engl J Med"},{"issue":"191","key":"10.1016\/j.semnephrol.2023.151437_bib0042","first-page":"429","article-title":"Bartter's syndrome: 10 cases in childhood. Results of long-term indomethacin therapy","volume":"48","author":"Dillon","year":"1979","journal-title":"Q J Med"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151437_bib0043","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1093\/ndt\/gfn689","article-title":"Phenotype-genotype correlation in antenatal and neonatal variants of Bartter syndrome","volume":"24","author":"Brochard","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151437_bib0044","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1447-0756.2000.tb01287.x","article-title":"Bartter's syndrome in pregnancy: a case report and review","volume":"26","author":"Li","year":"2000","journal-title":"J Obstet Gynaecol Res"},{"issue":"11","key":"10.1016\/j.semnephrol.2023.151437_bib0045","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/ncpneph0309","article-title":"Monogenic forms of low-renin hypertension","volume":"2","author":"Garovic","year":"2006","journal-title":"Nat Clin Pract Nephrol"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151437_bib0046","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","article-title":"Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism","volume":"113","author":"Shimada","year":"2004","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.semnephrol.2023.151437_bib0047","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1002\/j.1460-2075.1996.tb00594.x","article-title":"Identification of a PY motif in the epithelial Na channel subunits as a target sequence for mutations causing channel activation found in Liddle syndrome","volume":"15","author":"Schild","year":"1996","journal-title":"EMBO J"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151437_bib0048","doi-asserted-by":"crossref","first-page":"F377","DOI":"10.1152\/ajprenal.00143.2002","article-title":"Concerted action of ENaC, Nedd4-2, and Sgk1 in transepithelial Na(+) transport","volume":"283","author":"Kamynina","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2023.151437_bib0049","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2147\/IBPC.S188869","article-title":"Liddle's syndrome mechanisms, diagnosis and management","volume":"12","author":"Enslow","year":"2019","journal-title":"Integr Blood Press Control"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151437_bib0050","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/HJH.0000000000001556","article-title":"Analysis of the genes involved in Mendelian forms of low-renin hypertension in Chinese early-onset hypertensive patients","volume":"36","author":"Liu","year":"2018","journal-title":"J Hypertens"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151437_bib0051","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/00000441-200112000-00002","article-title":"Liddle syndrome: genetics and mechanisms of Na+ channel defects","volume":"322","author":"Warnock","year":"2001","journal-title":"Am J Med Sci"},{"issue":"26","key":"10.1016\/j.semnephrol.2023.151437_bib0052","doi-asserted-by":"crossref","first-page":"15370","DOI":"10.1073\/pnas.93.26.15370","article-title":"Cell surface expression of the epithelial Na channel and a mutant causing Liddle syndrome: a quantitative approach","volume":"93","author":"Firsov","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.semnephrol.2023.151437_bib0053","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1097\/01.ASN.0000080204.65527.E6","article-title":"Dysfunction of the epithelial sodium channel expressed in the kidney of a mouse model for Liddle syndrome","volume":"14","author":"Pradervand","year":"2003","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.semnephrol.2023.151437_bib0054","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1681\/ASN.2016111163","article-title":"A missense mutation in the extracellular domain of \u03b1ENaC causes Liddle syndrome","volume":"28","author":"Salih","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2023.151437_bib0055","doi-asserted-by":"crossref","first-page":"37","DOI":"10.5414\/CNCS109972","article-title":"A case report of three children with secondary hypertension caused by Liddle syndrome","volume":"8","author":"Teoh","year":"2020","journal-title":"Clin Nephrol Case Stud"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151437_bib0056","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/jch.12949","article-title":"Liddle syndrome: clinical and genetic profiles","volume":"19","author":"Cui","year":"2017","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"12","key":"10.1016\/j.semnephrol.2023.151437_bib0057","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1530\/EC-18-0484","article-title":"Liddle syndrome misdiagnosed as primary aldosteronism resulting from a novel frameshift mutation of SCNN1B","volume":"7","author":"Fan","year":"2018","journal-title":"Endocr Connect"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151437_bib0058","doi-asserted-by":"crossref","first-page":"812","DOI":"10.3390\/ijms19030812","article-title":"Liddle syndrome: review of the literature and description of a new case","volume":"19","author":"Tetti","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.semnephrol.2023.151437_bib0059","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1007\/s00467-012-2329-z","article-title":"Hereditary causes of kidney stones and chronic kidney disease","volume":"28","author":"Edvardsson","year":"2013","journal-title":"Pediatr Nephrol"},{"issue":"suppl 4","key":"10.1016\/j.semnephrol.2023.151437_bib0060","doi-asserted-by":"crossref","first-page":"iv33","DOI":"10.1093\/ndt\/gfu231","article-title":"Protein trafficking defects in inherited kidney diseases","volume":"29","author":"Schaeffer","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"21","key":"10.1016\/j.semnephrol.2023.151437_bib0061","doi-asserted-by":"crossref","first-page":"13929","DOI":"10.1074\/jbc.272.21.13929","article-title":"Bafilomycin A1 treatment retards transferrin receptor recycling more than bulk membrane recycling","volume":"272","author":"Presley","year":"1997","journal-title":"J Biol Chem"},{"issue":"17","key":"10.1016\/j.semnephrol.2023.151437_bib0062","doi-asserted-by":"crossref","first-page":"7014","DOI":"10.1073\/pnas.1302063110","article-title":"Receptor-mediated endocytosis and endosomal acidification is impaired in proximal tubule epithelial cells of Dent disease patients","volume":"110","author":"Gorvin","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2023.151437_bib0063","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/403272","article-title":"Molecular mechanisms of receptor-mediated endocytosis in the renal proximal tubular epithelium","volume":"2010","author":"Saito","year":"2010","journal-title":"J Biomed Biotechnol"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151437_bib0064","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1086\/427887","article-title":"Dent disease with mutations in OCRL1","volume":"76","author":"Hoopes","year":"2005","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151437_bib0065","doi-asserted-by":"crossref","first-page":"p27","DOI":"10.1159\/000213506","article-title":"OCRL1 mutations in Dent 2 patients suggest a mechanism for phenotypic variability","volume":"112","author":"Shrimpton","year":"2009","journal-title":"Nephron Physiol"},{"issue":"3-4","key":"10.1016\/j.semnephrol.2023.151437_bib0066","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/hmg\/ddab025","article-title":"Genotype & phenotype in Lowe syndrome: specific OCRL1 patient mutations differentially impact cellular phenotypes","volume":"30","author":"Ramadesikan","year":"2021","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151437_bib0067","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00439-020-02219-2","article-title":"Genetics and phenotypic heterogeneity of Dent disease: the dark side of the moon","volume":"140","author":"Gianesello","year":"2021","journal-title":"Hum Genet"},{"issue":"8","key":"10.1016\/j.semnephrol.2023.151437_bib0068","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/s41581-019-0159-y","article-title":"Mechanisms of phosphate transport","volume":"15","author":"Levi","year":"2019","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151437_bib0069","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00467-017-3873-3","article-title":"Renal phosphate handling and inherited disorders of phosphate reabsorption: an update","volume":"34","author":"Wagner","year":"2019","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151437_bib0070","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41574-022-00662-x","article-title":"Interdisciplinary management of FGF23-related phosphate wasting syndromes: a Consensus Statement on the evaluation, diagnosis and care of patients with X-linked hypophosphataemia","volume":"18","author":"Trombetti","year":"2022","journal-title":"Nat Rev Endocrinol"},{"issue":"8","key":"10.1016\/j.semnephrol.2023.151437_bib0071","doi-asserted-by":"crossref","first-page":"e1306","DOI":"10.1002\/mgg3.1306","article-title":"Phenotypic spectrum and antialbuminuric response to angiotensin converting enzyme inhibitor and angiotensin receptor blocker therapy in pediatric Dent disease","volume":"8","author":"Deng","year":"2020","journal-title":"Mol Genet Genomic Med"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151437_bib0072","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.kint.2016.04.022","article-title":"Observations of a large Dent disease cohort","volume":"90","author":"Blanchard","year":"2016","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151437_bib0073","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/ndt\/gfac310","article-title":"Clinical and genetic characteristics of Dent's disease type 1 in Europe","volume":"38","author":"Burballa","year":"2023","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"10.1016\/j.semnephrol.2023.151437_bib0074","first-page":"473","article-title":"Dent's disease; a familial proximal renal tubular syndrome with low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, metabolic bone disease, progressive renal failure and a marked male predominance","volume":"87","author":"Wrong","year":"1994","journal-title":"QJM"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151437_bib0075","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1086\/499410","article-title":"Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3","volume":"78","author":"Lorenz-Depiereux","year":"2006","journal-title":"Am J Hum Genet"},{"issue":"8","key":"10.1016\/j.semnephrol.2023.151437_bib0076","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/jbmr.3475","article-title":"A randomized, double-blind, placebo-controlled, phase 3 trial evaluating the efficacy of burosumab, an anti-FGF23 antibody, in adults with X-linked hypophosphatemia: week 24 primary analysis","volume":"33","author":"Insogna","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151437_bib0077","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00223-019-00568-3","article-title":"Continued beneficial effects of burosumab in adults with X-linked hypophosphatemia: results from a 24-week treatment continuation period after a 24-week double-blind placebo-controlled period","volume":"105","author":"Portale","year":"2019","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151437_bib0078","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1523-1755.1998.00718.x","article-title":"X-linked hypercalciuric nephrolithiasis: clinical syndromes and chloride channel mutations","volume":"53","author":"Scheinman","year":"1998","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.semnephrol.2023.151437_bib0079","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1097\/01.ASN.0000036869.82685.F6","article-title":"Responsiveness of hypercalciuria to thiazide in Dent's disease","volume":"13","author":"Raja","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151437_bib0080","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1523-1755.2005.00442.x","article-title":"High citrate diet delays progression of renal insufficiency in the ClC-5 knockout mouse model of Dent's disease","volume":"68","author":"Cebotaru","year":"2005","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.semnephrol.2023.151437_bib0081","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nrneph.2010.69","article-title":"Pathophysiology and treatment of cystinuria","volume":"6","author":"Chillar\u00f3n","year":"2010","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151437_bib0082","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1073\/pnas.1519959113","article-title":"Novel cystine transporter in renal proximal tubule identified as a missing partner of cystinuria-related plasma membrane protein rBAT\/SLC3A1","volume":"113","author":"Nagamori","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151437_bib0083","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1523-1755.2005.67100.x","article-title":"Transient neonatal cystinuria","volume":"67","author":"Boutros","year":"2005","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.semnephrol.2023.151437_bib0084","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.2215\/CJN.11191210","article-title":"An update on the changing epidemiology and metabolic risk factors in pediatric kidney stone disease","volume":"6","author":"Sas","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151437_bib0085","first-page":"681","article-title":"Cystinuria: review of a life-long and frustrating disease","volume":"94","author":"Kowalczyk","year":"2021","journal-title":"Yale J Biol Med"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151437_bib0086","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0022-5347(05)64037-2","article-title":"Durability of the medical management of cystinuria","volume":"169","author":"Pietrow","year":"2003","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151437_bib0087","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S0022-5347(17)45188-3","article-title":"Management of cystine nephrolithiasis with alpha-mercaptopropionylglycine","volume":"136","author":"Pak","year":"1986","journal-title":"J Urol"},{"issue":"10","key":"10.1016\/j.semnephrol.2023.151437_bib0088","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1681\/ASN.V12102170","article-title":"Characterization of a putative founder mutation that accounts for the high incidence of cystinosis in Brittany","volume":"12","author":"Kalatzis","year":"2001","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151437_bib0089","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/MOP.0000000000000462","article-title":"Nephropathic cystinosis: an update","volume":"29","author":"Veys","year":"2017","journal-title":"Curr Opin Pediatr"},{"issue":"7","key":"10.1016\/j.semnephrol.2023.151437_bib0090","doi-asserted-by":"crossref","first-page":"971","DOI":"10.4161\/auto.6.7.13099","article-title":"Abnormal mitochondrial autophagy in nephropathic cystinosis","volume":"6","author":"Sansanwal","year":"2010","journal-title":"Autophagy"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151437_bib0091","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1681\/ASN.2019070712","article-title":"Use of human induced pluripotent stem cells and kidney organoids to develop a cysteamine\/mTOR inhibition combination therapy for cystinosis","volume":"31","author":"Hollywood","year":"2020","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151437_bib0092","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1172\/JCI108448","article-title":"Intracellular cystine depletion by aminothiols in vitro and in vivo","volume":"58","author":"Thoene","year":"1976","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151437_bib0093","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMra020552","volume":"347","author":"Gahl","year":"2002","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151437_bib0094","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/ki.2011.277","article-title":"Cysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults","volume":"81","author":"Brodin-Sartorius","year":"2012","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151437_bib0095","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.kint.2021.06.019","article-title":"An international cohort study spanning five decades assessed outcomes of nephropathic cystinosis","volume":"100","author":"Emma","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2023.151437_bib0096","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13023-016-0426-y","article-title":"Cystinosis: a review","volume":"11","author":"Elmonem","year":"2016","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151437_bib0097","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s00467-020-04638-9","article-title":"Nephropathic cystinosis: an update on genetic conditioning","volume":"36","author":"Topaloglu","year":"2021","journal-title":"Pediatr Nephrol"},{"issue":"9","key":"10.1016\/j.semnephrol.2023.151437_bib0098","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1093\/ckj\/sfac099","article-title":"Expert guidance on the multidisciplinary management of cystinosis in adolescent and adult patients","volume":"15","author":"Levtchenko","year":"2022","journal-title":"Clin Kidney J"},{"issue":"suppl 4","key":"10.1016\/j.semnephrol.2023.151437_bib0099","doi-asserted-by":"crossref","first-page":"iv87","DOI":"10.1093\/ndt\/gfu090","article-title":"Nephropathic cystinosis: an international consensus document","volume":"29","author":"Emma","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151437_bib0100","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1179\/2295333714Y.0000000113","article-title":"Cystinosis: a new perspective","volume":"71","author":"Veys","year":"2016","journal-title":"Acta Clin Belg"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151437_bib0101","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"7","key":"10.1016\/j.semnephrol.2023.151437_bib0102","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41581-019-0152-5","article-title":"Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia","volume":"15","author":"Haffner","year":"2019","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151437_bib0103","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00439-009-0631-z","article-title":"PHEX analysis in 118 pedigrees reveals new genetic clues in hypophosphatemic rickets","volume":"125","author":"Gaucher","year":"2009","journal-title":"Hum Genet"},{"issue":"7","key":"10.1016\/j.semnephrol.2023.151437_bib0104","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s004670050669","article-title":"PHEX expression in parathyroid gland and parathyroid hormone dysregulation in X-linked hypophosphatemia","volume":"13","author":"Blydt-Hansen","year":"1999","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151437_bib0105","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13023-019-1014-8","article-title":"FGF23 and its role in X-linked hypophosphatemia-related morbidity","volume":"14","author":"Beck-Nielsen","year":"2019","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151437_bib0106","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1086\/499409","article-title":"SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis","volume":"78","author":"Bergwitz","year":"2006","journal-title":"Am J Hum Genet"},{"issue":"21","key":"10.1016\/j.semnephrol.2023.151437_bib0107","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1056\/NEJMoa1714641","article-title":"Burosumab therapy in children with X-linked hypophosphatemia","volume":"378","author":"Carpenter","year":"2018","journal-title":"N Engl J Med"},{"issue":"10189","key":"10.1016\/j.semnephrol.2023.151437_bib0108","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/S0140-6736(19)30654-3","article-title":"Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial","volume":"393","author":"Imel","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2023.151437_bib0109","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.752312","article-title":"Childhood hypercalciuric hypercalcemia with elevated vitamin D and suppressed parathyroid hormone: long-term follow up","volume":"9","author":"Gurevich","year":"2021","journal-title":"Front Pediatr"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027092952300147X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027092952300147X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T18:20:05Z","timestamp":1762280405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027092952300147X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":109,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S027092952300147X"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2023.151437","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tubular Diseases and Stones Seen From Pediatric and Adult Nephrology Perspectives","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2023.151437","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"151437"}}